On November 12th, PW MEDTECH (01358) spent 1.034 million Hong Kong dollars to repurchase 1 million shares.
PwC Holdings Limited (01358) announced on November 12, 2024 that it will spend HK$103.4 million to repurchase its shares.
PW MEDTECH (01358) announced that on November 12, 2024, it will spend 1.034 million Hong Kong dollars to repurchase 1 million shares at a repurchase price of 1.03-1.04 Hong Kong dollars per share.
Related Articles
STANCHART (02888) spent 9.8582 million pounds to repurchase 549,000 shares on January 9th.
HAITONG UT (01905) plans to issue corporate bonds not exceeding 1 billion yuan.
Chengdu Olymvax Biopharmaceuticals Inc (688319.SH) submitted an application for the issuance of H shares, and the materials have been accepted by the China Securities Regulatory Commission.
STANCHART (02888) spent 9.8582 million pounds to repurchase 549,000 shares on January 9th.
HAITONG UT (01905) plans to issue corporate bonds not exceeding 1 billion yuan.
Chengdu Olymvax Biopharmaceuticals Inc (688319.SH) submitted an application for the issuance of H shares, and the materials have been accepted by the China Securities Regulatory Commission.
RECOMMEND
Patent Cliff Looms As Pharmaceutical Sector Prepares For A New Round Of Asset Competition
10/01/2026
Goldman Sachs Remains Bullish On China Equities: AI And Overseas Expansion To Drive Earnings, MSCI China Seen Rising 20% In 2026
10/01/2026
“A+H” Popularity Continues As Multiple A‑Share Companies Announce Hong Kong Listings At The Start Of The Year
10/01/2026
